A
ATX
AMPLIA THERAPEUTICS
0.145
-0.005-3.33%Opening13:21 05/27 AEST
OPEN/PREV CLOSE0.145/0.150
TODAY RANGE0.140-0.145
VOL106.38K
MARKET CAP74.43M
52 WEEK RANGE0.049-0.425
AVG VOL (3M)7.14M
% TURNOVER0.02%
TURNOVER14.94K
P/E (TTM)-7.1078
% RANGE3.33%
EPS(TTM)-0.0204
P/E(FORWARD)-7.2500
P/B1.732
BVPS0.084
DIVIDEND--
P/S14.95
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP63.10M
SHARES OUTSTANDING513.31M
NEXT EARNINGS05/26-06/08
FREE FLOAT435.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
ASX·05/12 05:49
Notice under Section 708A(5)(e) of the Corporations Act
ASX·05/12 05:29
Application for quotation of securities - ATX
ASX·05/07 22:31
Amplia and ANZGOG announce Ovarian Cancer Study
ASX·04/28 00:00
Amplia Therapeutics Ltd Prelim Q4
ASX·04/21 22:29
ACCENT Trial Mature Data Presented at AACR Conference
ASX·04/08 04:08
Amplia MD Responds to Questions Regarding AMPLICITY Trial
The Motley Fool·04/07 03:38
Down 30% today, is it time to buy into this beaten down biotech share?
ASX·04/06 22:41
Amplia Therapeutics Halts Recruitment in AMPLICITY Trial
The Motley Fool·03/23 21:42
Why this promising small-cap ASX stock could rise almost 80%
ASX·03/22 22:37
Amplia Reports Improved Responses & Survival in ACCENT trial
ASX·03/18 23:58
Trading Halt
ASX·03/18 22:54
Pause in Trading
ASX·03/08 21:16
Benefit of Narmafotinib in kRas-Mutated Cancer Models
ASX·02/24 21:11
Appointment of Chief Financial Officer
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others